UK losing up to £6.5bn a year in EU trade due to mismatched product rules, thinktank finds

IPPR report says failure to align testing standards has cost 0.18% of national income, with manufacturers abandoning exports or setting up EU subsidiaries

By LineZotpaper
Published
Read Time2 min
Sources2 outlets
The UK is missing out on annual exports to the European Union worth as much as £6.5bn because successive governments have failed to secure a mutual recognition agreement that would eliminate duplicate product testing, according to a new report from the Institute for Public Policy Research (IPPR).

The IPPR thinktank’s analysis, released on Thursday, is the latest attempt to quantify the trade loss inflicted by post-Brexit barriers. It calculates that many companies have simply given up selling goods to the EU or have set up subsidiaries inside the bloc to avoid the extra administration costs imposed by mismatched testing standards.

The manufacturing sectors have been hit hardest. Motor vehicle and parts exports would have been between £2.48bn and £3.42bn higher each year without the current friction, the report found. Electronic exports could have been between £1.17bn and £1.67bn higher, while pharmaceutical exports would have seen an estimated annual uplift of between £740m and £820m.

In total, the lost trade amounts to roughly 0.18% of UK national income, the IPPR said. The thinktank called for a renewed push to negotiate a mutual recognition agreement with Brussels, arguing that the current patchwork of rules imposes a disproportionate burden on smaller firms that lack the resources to establish EU subsidiaries.

§

Analysis

Why This Matters

  • The lost trade directly hits UK economic growth and living standards, with 0.18% of national income forfeited each year.
  • Small and medium-sized exporters are disproportionately affected, potentially forcing more businesses to relocate operations to the EU.
  • The report adds pressure on the government to reopen trade negotiations with Brussels, a politically sensitive step given ongoing divisions over Brexit.

Background

Since leaving the EU single market in 2021, the UK and EU have operated under a Trade and Cooperation Agreement that does not include mutual recognition of product testing standards. This means goods exported from the UK must undergo separate conformity assessments to meet EU regulations, adding time, cost and paperwork. Successive UK governments have explored but not concluded a mutual recognition agreement (MRA) that would allow manufacturers to use a single set of tests for both markets. Similar MRAs exist between the EU and other countries such as Australia and New Zealand.

Key Perspectives

UK exporters: Face higher costs and bureaucracy for selling into their largest market; many have shifted supply chains or set up EU-based entities to bypass the barriers, reducing domestic production and jobs. EU consumers and businesses: Benefit from continued access to UK goods through alternative channels, but may face slightly higher prices or reduced choice if UK firms exit the market. Skeptics of closer alignment: Argue that diverging from EU rules was one of the main benefits of Brexit and that an MRA could constrain the UK’s ability to set its own regulatory standards in future.

What to Watch

  • Whether the UK government signals willingness to restart MRA negotiations with the EU, especially as the next general election approaches.
  • The European Commission’s response: Brussels has previously insisted that any MRA be conditional on dynamic alignment with EU rules, a red line for many Brexit supporters.
  • Sector-specific impacts: If pharmaceutical companies continue to relocate, the UK’s position as a life-sciences hub could erode further.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.